A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients

Clinical trial NCT03736473 · COMPLETED

Trial details

NCT number: NCT03736473
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2018-11-07
Primary completion: 2019-06-19
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.